News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Eli Lilly (LLY) Gains FDA Breakthrough Therapy Designation for Abemaciclib     10/9/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
Celsion (CLSN) Updates Clinical Trial Data and Slashes 20% of Workforce     9/9/2015
Joining the Anti-PD-L1 Cancer Drug Market, Syndax Inks Deal With Genentech (RHHBY), Closes on $80 Million Series C Round     8/27/2015
Massachusetts' Syndax Banks $80 Million Series C     8/24/2015
A Daily Glass of Wine Increases Risks of Breast Cancer in Women, BMJ Study     8/20/2015
Oasmia's Paclical Does Well in Head to Head Study with Celgene (CELG)'s Abraxane     8/4/2015
Exciting Time for Biotech in New Jersey     6/29/2015
ASCO15 EXCLUSIVE: Berg’s Lead Cancer Drug May Shift Cancer Metabolism, Says CEO     6/4/2015
ASCO15 EXCLUSIVE: Merck & Co. (MRK)’s Breast Cancer Drug Beats Chemo Rates and Will Roll Into Phase III, Says Investigator     6/1/2015
ASCO15: Pfizer (PFE)'s Ibrance Slows Progression of Breast Cancer in Late-Stage Study     6/1/2015
Puma Biotech (PBYI) Founder Loses $250 Million on Disappointing Breast Cancer Drug Data     5/15/2015
Pfizer (PFE) Beams As Cancer Drug Efficacy Stops Trial Early and Analysts Predict Game Changer     4/17/2015
Roche (RHHBY) Says 11 Late-Stage Cancer Drugs Will Enter Trials in 2015     4/15/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry     3/20/2015

News from Around the Web
New Method To Predict Increased Risk Of Breast Cancer, Uppsala Universitet Study     10/2/2015
Virginia Tech Scientists Use Microchip Approach To Visualize Human Breast Cancer Proteins     9/28/2015
Western University Hopes To Use Artificial Intelligence To Improve Breast Cancer Patient Outcomes     9/18/2015
New Approach To Mammograms Could Improve Reliability, American Chemical Society Reveals     9/18/2015
Virus In Cattle Linked To Human Breast Cancer, University of California, Berkeley (CAL) Study     9/16/2015
New "Mutation-Tracking" Blood Test Could Predict Breast Cancer Relapse Months In Advance, The Institute of Cancer Research Study     8/27/2015
Photoacoustic Approach To Breast Cancer Detection, University of Twente Study     7/14/2015
Helmholtz Center In Munich Scientists Growing Mini Breasts To Study Cancer     6/15/2015
Soyfoods Reduce Breast Cancer Recurrence, University Medical Center Study     4/20/2015
Cancer Research Uncovers The Fountain Of Youth, University of Toronto Study     4/10/2015
How Artificial Light Can Mess With Your Health, University of Connecticut Researchers Say     3/20/2015
Genentech (RHHBY) Dives Into Apps to Help Cancer Patients     3/4/2015
A New Weapon In The Fight Against Cancer, Concordia University Reveals     2/20/2015
Unhealthy Insulin Levels May Boost Breast Cancer Risk, Imperial College London Study     1/16/2015
Hold Your Breath To Protect Your Heart, Thomas Jefferson University Study     1/7/2015

Press Releases
Lion Biotechnologies, Inc. Obtains Exclusive License From NIH To Develop And Commercialize TIL In Bladder, Lung, Breast And HPV-Associated Cancers     10/7/2015
GTX Corp Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm In Triple Negative Breast Cancer     10/6/2015
OncoSec Medical Inc. To Present At Investment Conferences In October     10/5/2015
Ambry Genetics Unveils Comprehensive Educational Resource Supporting People With Hereditary Breast And Ovarian Cancer     10/5/2015
Provista Diagnostics Offers Hope For The Early Detection Of Breast Cancer In Women With Dense Breasts     9/30/2015
GTx, Inc. (GTXI) Announces Enrollment Of First Patient In Phase 2 Clinical Trial Of Enobosarm in ER+/AR+ Breast Cancer     9/29/2015
Hologic (HOLX) Sinks as Study Questions Computer-Aided Mammograms     9/29/2015
Agendia BV Highlights Study Showing MammaPrint/BluePrint Tests Predict Response To Current Breast Cancer Chemotherapy And Targeted Therapy Regimens     9/29/2015
Heron (HRTX) Announces Oral Presentation Of Data From Completed Phase 3 MAGIC Study For SUSTOL At The ASCO Breast Cancer Symposium     9/28/2015
Puma Biotech (PBYI) Announces Presentation Of Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (Extenet Trial) In Centrally Confirmed HER2-Positive Early Stage Breast Cancer Patients     9/28/2015
Genomic Health, Inc. (GHDX) Release: Two Large International Studies Provide Additional Prospective Data Reinforcing The Ability Of Oncotype DX To Accurately Predict Clinical Outcomes In Early-Stage Breast Cancer Patients     9/28/2015
Genomic Health, Inc. (GHDX) Release: TAILORx Trial Finds 99 Percent Of Women With Low Oncotype DX Recurrence Score Are Free Of Breast Cancer Recurrence After Five Years Of Hormone Therapy Alone     9/28/2015
Tailorx Trial Finds 99% Of Women With Low Oncotype DX Recurrence Score Are Free Of Breast Cancer Recurrence After Five Years Of Hormone Therapy Alone     9/28/2015
Genomic Health, Inc. (GHDX) Responds To Flawed CMS Gap-Fill Pricing For Oncotype DX Breast Cancer Test     9/28/2015
Radius Health (RDUS) Announces Webcast On Investigational Drug RAD1901, Upcoming Presentations And Investor Day In New York City On November 17th, 2015     9/23/2015